Skip to main content
Clinical Trials/NCT04766346
NCT04766346
Completed
Not Applicable

Nutritional Supplementation in Children Aged 1-3 Years Experiencing Growth Concerns: a Prospective, Single-arm, Open-label, Interventional Study

Société des Produits Nestlé (SPN)1 site in 1 country168 target enrollmentFebruary 26, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Growth
Sponsor
Société des Produits Nestlé (SPN)
Enrollment
168
Locations
1
Primary Endpoint
The primary objective of this clinical trial is to to assess the effect of NS on weight gain and linear growth.
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

This open-label clinical trial will gain evidence of the effect of an oral Nutritional Supplement (NS) to help improve catch-up growth and support learning skills in children with growth concerns.

Registry
clinicaltrials.gov
Start Date
February 26, 2021
End Date
October 27, 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Sponsor
Société des Produits Nestlé (SPN)
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

The primary objective of this clinical trial is to to assess the effect of NS on weight gain and linear growth.

Time Frame: Day 1 to Day 113

The primary endpoint is the change in weight-for-length/height z-score

Secondary Outcomes

  • Sub-scapular skinfold thickness(Day 1, Day 22, Day 43, Day 64, Day 85, Day 113)
  • Suprailiac skinfold thickness(Day 1, Day 22, Day 43, Day 64, Day 85, Day 113)
  • Weight(Day 1, Day 22, Day 43, Day 64, Day 85, Day 113)
  • Length/height(Day 1, Day 22, Day 43, Day 64, Day 85, Day 113)
  • BMI(Day 1, Day 22, Day 43, Day 64, Day 85, Day 113)
  • Triceps skin fold thickness(Day 1, Day 22, Day 43, Day 64, Day 85, Day 113)
  • Z scores and percentiles(Day 1, Day 22, Day 43, Day 64, Day 85, Day 113)
  • Nutrient intake(Day 22, Day 43, Day 113)
  • Temperament and behavior(Day 1, Day 113)
  • Learning skills(Day 1, Day 113)
  • Child and parent well-being reported from the parents' perspective(Day 1, Day 113)
  • Product acceptance(Day 22, Day 64, Day 113)
  • Product acceptance including child-liking and post-ingestive effects(Day 22, Day 64, Day 113)

Study Sites (1)

Loading locations...

Similar Trials